Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Emerging Infectious Diseases|October 18, 2011
Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South AfricaMax R O'Donnell, Jennifer Zelnick, Lise Werner, et al.
PLOS Global Public Health|March 24, 2023
A scoping review of patient-centred tuberculosis care interventions: Gaps and opportunitiesHanlie Myburgh, Dzunisani Baloyi, Marian Loveday, et al.
British Journal of Clinical Pharmacology|May 8, 2022
Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin-resistant tuberculosisRichard Court, Kamunkhwala Gausi, Buyisile Mkhize, et al.
Journal of Midwifery & Women'S Health|July 3, 2007
Community-based situation analysis of maternal and neonatal care in South Africa to explore factors that impact utilization of maternal health servicesPulani Tlebere, Debra Jackson, Marian Loveday, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant TuberculosisNesri Padayatchi, Naressa Naidu, Nonhlanhla Yende-Zuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2020
Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South AfricaMarian Loveday, Jennifer Hughes, Babu Sunkari, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 10, 2022
Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milkPhiwe Zuma, Anton Joubert, Marthinus van der Merwe, et al.
British Journal of Clinical Pharmacology|December 2, 2025
Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin-resistant tuberculosisSharon Sawe, Lufina Tsirizani, Buyisile Mkhize, et al.
Pageof 6